Works by Jifeng Feng

Results: 185
    1
    2

    Identification of internal control genes for circular RNAs.

    Published in:
    Biotechnology Letters, 2019, v. 41, n. 10, p. 1111, doi. 10.1007/s10529-019-02723-0
    By:
    • Zhong, Shanliang;
    • Zhou, Siying;
    • Yang, Sujin;
    • Yu, Xinnian;
    • Xu, Hanzi;
    • Wang, Jinyan;
    • Zhang, Qian;
    • Lv, Mengmeng;
    • Feng, Jifeng
    Publication type:
    Article
    3
    4

    Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double‐Blinded, Placebo‐Controlled, Randomized Phase III Trial (ALTER0703).

    Published in:
    Oncologist, 2021, v. 26, n. 10, p. e1693, doi. 10.1002/onco.13857
    By:
    • Chi, Yihebali;
    • Shu, Yongqian;
    • Ba, Yi;
    • Bai, Yuxian;
    • Qin, Baoli;
    • Wang, Xiuwen;
    • Xiong, Jianping;
    • Xu, Nong;
    • Zhang, Helong;
    • Zhou, Jianfeng;
    • Xu, Jianming;
    • Cheng, Ying;
    • Feng, Jifeng;
    • Hu, Chunhong;
    • Chen, Yigui;
    • Chen, Zhendong;
    • Wang, Jufeng;
    • Dang, Chengxue;
    • Wang, Jianhong;
    • Wan, Yiye
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Central nervous system efficacy of furmonertinib (AST2818) in patients with EGFR T790M mutated non-small cell lung cancer: a pooled analysis from two phase 2 studies.

    Published in:
    BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02865-z
    By:
    • Hu, Xingsheng;
    • Zhang, Shucai;
    • Ma, Zhiyong;
    • Feng, Jifeng;
    • Wu, Lin;
    • Lv, Dongqing;
    • Zhou, Jianying;
    • Zhang, Xiaodong;
    • Liu, Li;
    • Yu, Qitao;
    • Liao, Wangjun;
    • Zhang, Yiping;
    • Wang, Xiang;
    • Cheng, Ying;
    • Niu, Hongrui;
    • Wang, Ziping;
    • Wang, Dong;
    • Huang, Cheng;
    • Liu, Chunling;
    • Zhao, Hui
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study

    Published in:
    Cancer Medicine, 2020, v. 9, n. 14, p. 5134, doi. 10.1002/cam4.3123
    By:
    • Chang, Jianhua;
    • Chen, Gongyan;
    • Wang, Dong;
    • Wang, Guihua;
    • Lu, Shun;
    • Feng, Jifeng;
    • Li, Wei;
    • Li, Ping;
    • Lanzarotti, Corinna;
    • Chessari, Salvatore;
    • Zhang, Li
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37

    Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.709877
    By:
    • Passaro, Antonio;
    • de Marinis, Filippo;
    • Tu, Hai-Yan;
    • Laktionov, Konstantin K.;
    • Feng, Jifeng;
    • Poltoratskiy, Artem;
    • Zhao, Jun;
    • Tan, Eng Huat;
    • Gottfried, Maya;
    • Lee, Victor;
    • Kowalski, Dariusz;
    • Yang, Cheng Ta;
    • Srinivasa, BJ;
    • Clementi, Laura;
    • Jalikop, Tejaswini;
    • Huang, Dennis Chin Lun;
    • Cseh, Agnieszka;
    • Park, Keunchil;
    • Wu, Yi-Long
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    CLASRP oncogene as a novel target for colorectal cancer.

    Published in:
    Functional & Integrative Genomics, 2023, v. 23, n. 3, p. 1, doi. 10.1007/s10142-023-01208-8
    By:
    • Gu, Quan;
    • Wu, Jianzhong;
    • Xu, Heng;
    • Cao, Haixia;
    • Zhang, Junying;
    • Jing, Changwen;
    • Wang, Zhuo;
    • Du, Mengjie;
    • Ma, Rong;
    • Feng, Jifeng
    Publication type:
    Article
    50